Flerie Invest

Venture Capital Stockholm, Sweden ·Founded 2010

Overview

Flerie Invest is a proactive, long-term investor specializing in biotech and pharmaceutical investments globally. With offices in Stockholm and London, Flerie Invest manages a diverse portfolio of over 30 companies across Europe, Israel, and the United States. The firm's focus is on enabling pioneering organizations in drug development and related services to succeed by providing essential resources and expertise. The portfolio encompasses a wide range of areas, including immuno-oncology, metabolic diseases, and biologics development and manufacturing organizations, all with the potential to make a significant impact on health and well-being. Flerie Invest was founded in 2010 by Thomas Eldered, who also co-founded and built Recipharm into one of the world's top five pharmaceutical contract manufacturers.

Investment Focus

  • Focus on drug development and related services
  • Potential for significant impact on health and well-being
  • Located in Europe, Israel, or the United States

Portfolio Companies

InDex PharmaceuticalsToleranzia ABXintela ABLipum ABEmpros Pharma ABAmarna Therapeutics B.V.NorthX Biologics Holding ABProvell Pharmaceuticals LLC

Reach Flerie Invest directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Flerie Invest

What sectors does Flerie Invest invest in?

Flerie Invest invests in Healthcare, Digital Health, Pharmaceuticals, Medtech and Biotechnology, and is based in Stockholm, Sweden. Flerie Invest is listed as a venture capital in the ConnectSafely investor database.

What stage does Flerie Invest invest at?

Flerie Invest backs companies at Early Stage, Series A and Series B.

Which regions does Flerie Invest invest in?

Flerie Invest invests across United States, United Kingdom, Netherlands, Sweden, Israel and Iceland.

Who are the partners at Flerie Invest?

Team members listed for Flerie Invest include Ted Fjallman (Chief Executive Officer) and Thomas Eldered (Executive Chairman).

What companies has Flerie Invest invested in?

Flerie Invest's portfolio includes InDex Pharmaceuticals, Toleranzia AB, Xintela AB, Lipum AB, Empros Pharma AB, Amarna Therapeutics B.V., NorthX Biologics Holding AB and Provell Pharmaceuticals LLC.

How do I contact Flerie Invest?

Flerie Invest's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database